AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

IRCE

Transaction in Own Shares Mar 24, 2020

4035_dirs_2020-03-24_f53404f5-3d9f-46a7-81af-1f244e45d0ce.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

REPORT ON THE PURCHASE AND ALLOCATION OF OWN SHARES

Dear shareholders,

The Board of Directors of IRCE S.p.A. resolved, on 13th March 2020, to submit to the Shareholders' Meeting a proposal for authorization to purchase and allocate own shares, in accordance with Articles 2357 et seq. of the Italian Civil Code.

The aforementioned authorization is requested in order to provide the company – according to a widespread practice amongst listed companies – with an appropriate tool to operate within the stock market, thereby allowing for the stabilization of the stock and preventing contingent and merely speculative situations with the effect of improving the liquidity of the stock itself.

In particular, the Board of Directors resolved to submit to the Shareholders' Meeting the following proposal:

  • IRCE S.p.A. shares may be purchased in compliance with the provisions of Article 132 of Italian Legislative Decree No. 58 of 24 February 1998 and in accordance with the operational modalities pursuant to Article 144-bis of CONSOB Issuers' Regulations.
  • the aforementioned authorization will have a duration of 18 months and during which the purchases and sales may be implemented in multiple transactions, providing the Chairman with all powers required to implement the purchases and sales, even by means of proxies, while complying with that potentially required by the competent authorities;
  • the purchase price may not be less than 80%, nor greater than 120% of the reference price recorded by the IT System of the Italian Stock Exchange during the session prior to each individual purchase transaction;
  • the purchase must be made within the limits of distributable profits and available reserves, entering them in the balance sheet liabilities, as required by art. 2357-ter of the civil code, a specific item, with a negative sign. Purchases and disposals of treasury shares will be accounted for according to the laws and accounting principles applied;
  • the Board of Directors, and the Chairman on behalf of the latter, may allocate, without time limits, the own shares which were purchased in execution of previous resolutions; these shares may be sold, even with a public offering and/or to employees, at a price that is not less than 90% of the reference price recorded by the IT System of the Italian Stock Exchange during the session prior to each individual sales transaction or, alternatively, may be subject to exchange, swap, contribution or other allocation transactions under industrial projects or extraordinary financial transactions, and in these cases without price limits;
  • the nominal value of the purchased shares may not exceed one fifth of the capital. The number of own shares which can be purchased may not exceed 5,625,600 in number.

As of today's date, the company directly holds 1.546.988 shares representing 5,5% of the share capital.

With reference to distributable profits and available reserves which can be used for the purchase of own shares, the financial statements as of 31 December 2018 reported the following reserves:

Amount Possibility of use Quota available Distributable
14.626.560
40.538.732 A,B,C 40.538.732 40.538.732
6.035.757 A,B,C 6.035.757 6.035.757
46.574.489 46.574.489 46.574.489
2.925.312 B 2.925.312 -
35.047.471 A,B,C 35.047.471 35.047.471
5.847.255 A,B 5.847.255 1.597.853
-
723.990
- -
723.990 -
723.990
- A,B - -
585.888 A,B,C 585.888 585.888
43.681.935 43.681.935 36.507.222
201.160 A,B,C 201.160 201.160
22.327.500 A,B,C 22.327.500 22.327.500
13.935.343 A,B 13.935.343
36.464.003 36.464.003 22.528.660
126.720.428 105.610.371
126.720.428
Residual quota available 105.610.371
126.720.428
7.902.954
149.249.942
Total reserves available
Quota not available for legal reserves
Quota not available IAS
Quota not available fair value land
2.925.312
4.249.402
13.935.343

Legend

A = capital increase; B = loss coverage; C = distributable

Note 1

The share premium reserve can be distributed having the legal reserve already reached 1/5 of the share capital

For further information we attached also the restated financial statements as of 31 December 2019 that will be presented at the next Shareholders' Meeting:

Description Amount Possibility of use Quota avalaible Distributable
Share capital 14,626,560
Capital's reserves
Share premium reserve 40,538,732 A,B,C 40,538,732 40,538,732
Other reserves 6,035,757 A,B,C 6,035,757 6,035,757
Total capital's reserve 46,574,489 46,574,489 46,574,489
Earning's reserves
Legal 2,925,312 B 2,925,312 -
Extraordinary 41,620,289 A,B,C 41,620,289 41,620,289
IAS 5,709,132 A,B 5,709,132 1.597.853
Own shares -
767,153
- -
767,153 -
767,153
Cash flow hedge - A,B - -
Other reserves 585,888 A,B,C 585,888 585,888
Total earning's reserves 50,073,469 50,073,469 43,036,878
Reserves in tax suspension
The South incomes 201,160 A,B,C 201,160 201,160
Extraordinary revaluation in the financial statements 22,327,500 A,B,C 22,327,500 22,327,500
Reavluation n. 266/2005 13,935,343 A,B 13,935,343 -
Total reserves in tax suspension 36,464,003 36,464,003 22,528,660
Total reserves 133,111,960 133,111,961 112,140,027
Profit 2019 3,603,483
Total equity 151,342,003
Total reserves available 133,111,960
Not-assignable share for non-amortized start-up and expansion costs. -
Quota not avalaible for legal reserves 2,925,312
Quota not available IAS 4,111,279
Quota not avalaible fair value land 13,935,343
Residual quota available 112,140,027

Legend

A = capital increase; B = loss coverage; C = distributable

Note 1

The share premium reserve can be distributed having the legal reserve already reached 1/5 of the share capital

Imola, 13th March 2020

The Board of Directors

Talk to a Data Expert

Have a question? We'll get back to you promptly.